LaYow Yu
Reproducibility track record
1
assessed papers
73/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
0
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
—
Funders
—
Frequent co-authors
Alexander B. Kim 1Mary C. Fulbright 1Grant A. Challen 1Kailen Mark 1Sandra E. Dunn 1Fan He 1Li Ding 1Daniel A.C. Fisher 1Jingxian Liu 1Stacey Rentschler 1
Institutions
Washington University in St. Louis 1Stanford University 1James S. McDonnell Foundation 1Quantum Design (United States) 1
Geography (author institutions)
US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (24)
Request a reproduction →1 assessed by us (0 reproduced) · 23 not yet assessed — every PubMed paper on record, linked below.
-
Genetic Determinants of Wound Healing: Monogenic Disorders and Polygenic Influence ↗Cells · 2026 · PMID 41511357not yet assessed
-
Lower extremity osseointegration for amputees with diabetes mellitus and vascular disease ↗OTA International The Open Access Journal of Orthopaedic Trauma · 2026 · PMID 41783147not yet assessed
-
not yet assessed
-
Telemedicine in Plastic Surgery: A Systematic Review and Meta-analysis of Utilization and Outcomes Pre- and Post-pandemic ↗Aesthetic Plastic Surgery · 2026 · PMID 42045685not yet assessed
-
Outcomes and Challenges of Flap Reconstruction for Pressure Injuries in Clinically Complex Patients ↗Journal of Clinical Medicine · 2026 · PMID 42355980not yet assessed
-
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms ↗Blood · 2026 · PMID 42345360not yet assessed
-
not yet assessed
-
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemiaNature Communications · 2025 · PMID 39820365L1 73/100
-
Irrigation Solutions in Wound Care and Breast Surgery: Evidence-Based Applications, Regulatory Considerations, and Future Directions ↗Journal of Clinical Medicine · 2025 · PMID 41227074not yet assessed
-
Outcomes of Transfemoral Osseointegration for Patients With Prior Amputation to Manage Infected Total Knee Arthroplasty ↗HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · 2025 · PMID 40546985not yet assessed
-
Clinical implementation of MRI for evaluation of titanium press-fit osseointegration implants ↗OTA International The Open Access Journal of Orthopaedic Trauma · 2025 · PMID 40271207not yet assessed
-
The Impact of Climate-Related Natural Disasters and Extreme Weather Events on Plastic and Reconstructive Surgery: A Scoping Review ↗Cureus · 2025 · PMID 41625887not yet assessed
-
RSK1 dependency in FLT3-ITD acute myeloid leukemia ↗Blood Cancer Journal · 2024 · PMID 39592591not yet assessed
-
Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms ↗Journal of Clinical Investigation · 2023 · PMID 38060311not yet assessed
-
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms ↗American Journal of Hematology · 2023 · PMID 37203407not yet assessed
-
Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis ↗Cancer Pathogenesis and Therapy · 2023 · PMID 37750087not yet assessed
-
not yet assessed
-
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression ↗Nature Cancer · 2022 · PMID 36581736not yet assessed
-
not yet assessed
-
not yet assessed
-
Multiomic Profiling Reveals Metabolic Alterations Mediating Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms ↗bioRxiv (Cold Spring Harbor Laboratory) · 2022not yet assessed
-
not yet assessed
-
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression ↗bioRxiv (Cold Spring Harbor Laboratory) · 2021not yet assessed
-
DUSP6 Mediates Resistance to JAK2 Inhibition and Drives Myeloproliferative Neoplasm Disease Progression ↗Blood · 2021not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Yu L” paper on PubMed ↗